Three former executives at Magellan Diagnostics Inc. are charged with knowingly selling defective lead testing machines between 2013 and 2017 that generated inaccurate results for tens of thousands of children across the country and for clients of at least one international relief organization, federal prosecutors said.
Amy Winslow, 51, of Needham; Reba Daoust, 66, of Amesbury; and Mohammad Hossein Maleknia,64, of Bonita Springs, Fla., are accused of knowing the devices — including its Leadclear II product that accounted for 2.5 million tests in 2017, half of all tests conducted in the United States — had a manufacturing flaw that generated false negatives, giving parents the mistaken impression their children were safe, US Attorney Rachael Rollins’s office said Wednesday.
“We allege that these defendants deceived customers and the FDA about the reliability of medical tests that detected lead levels. By doing so, we assert that they endangered the health and lives of incredibly vulnerable victims,” Rollins said in a statement. “According to the CDC, there is no safe level of lead in the blood.”
This article is exclusive to STAT+ subscribers
Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.
Already have an account? Log in
Already have an account? Log in
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect